# Alice B. Gottlieb

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alice-b-gottlieb/

## Facts

| Field | Value |
| --- | --- |
| Citations | 49,716 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 111 |
| i10-index | 430 |
| Last Known Institution | The University of Texas Southwestern Medical Center |
| OpenAlex ID | https://openalex.org/A5049859852 |
| ORCID iD | https://orcid.org/0000-0002-2927-8618 |
| Works | 853 |

## Researcher papers

- [Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics](https://scholariq.org/papers/joint-aad-npf-guidelines-of-care-for-the-management-and-treatment-of-psoriasis/)
- [Psoriasis](https://scholariq.org/papers/psoriasis/)
- [Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa](https://scholariq.org/papers/two-phase-3-trials-of-adalimumab-for-hidradenitis-suppurativa/)
- [Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies](https://scholariq.org/papers/prevalence-of-psoriatic-arthritis-in-patients-with-psoriasis-a-systematic-review/)
- [Guidelines of care for the management of psoriasis and psoriatic arthritis](https://scholariq.org/papers/guidelines-of-care-for-the-management-of-psoriasis-and-psoriatic-arthritis/)
- [Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities](https://scholariq.org/papers/joint-aad-npf-guidelines-of-care-for-the-management-and-treatment-of-psoriasis-2/)
- [Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial](https://scholariq.org/papers/ixekizumab-for-the-treatment-of-patients-with-active-psoriatic-arthritis-and-an/)
- [Etanercept Treatment for Children and Adolescents with Plaque Psoriasis](https://scholariq.org/papers/etanercept-treatment-for-children-and-adolescents-with-plaque-psoriasis/)
- [Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies](https://scholariq.org/papers/joint-american-academy-of-dermatology-national-psoriasis-foundation-guidelines/)
- [Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures](https://scholariq.org/papers/joint-aad-npf-guidelines-of-care-for-the-management-and-treatment-of-psoriasis-3/)
- [Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials](https://scholariq.org/papers/secukinumab-in-moderate-to-severe-hidradenitis-suppurativa-sunshine-and-sunrise/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

## Researcher university

- [The University of Texas Southwestern Medical Center](https://scholariq.org/institutions/the-university-of-texas-southwestern-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.